{"log_id": 4857004771296613453, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 7e-06, "average": 0.998823, "min": 0.984651}, "location": {"width": 723, "top": 248, "height": 35, "left": 240}, "words": "究中重要不良事件的发生率和严重程度均以表格的形式在上面列出。另外,在上"}, {"probability": {"variance": 0.000111, "average": 0.996715, "min": 0.936813}, "location": {"width": 724, "top": 289, "height": 35, "left": 240}, "words": "市后的使用中或者在其他临床研究中,也有罕见的不良事件的报道。在接受紫杉"}, {"probability": {"variance": 1.3e-05, "average": 0.998118, "min": 0.983536}, "location": {"width": 725, "top": 330, "height": 36, "left": 238}, "words": "醇治疗的卵巢癌、乳腺癌、非小细胞肺癌、卡波氏肉瘤患者中,不良事件的发生"}, {"probability": {"variance": 0.005658, "average": 0.981056, "min": 0.551442}, "location": {"width": 701, "top": 371, "height": 35, "left": 240}, "words": "率和严重程度通常相似,只是在AIDS相关性卡波氏肉瘤患者中,造血系统毒性"}, {"probability": {"variance": 0.001796, "average": 0.991367, "min": 0.744623}, "location": {"width": 724, "top": 414, "height": 32, "left": 238}, "words": "感染(包括机会性感染)、中性粒细胞减少性发热的发生更频繁、更严重。这些"}, {"probability": {"variance": 0.006325, "average": 0.985169, "min": 0.521614}, "location": {"width": 722, "top": 454, "height": 36, "left": 238}, "words": "患者需要一个相对低的剂量强度,并且需要支持治疗。只在卡波氏肉瘤患者中发"}, {"probability": {"variance": 1.1e-05, "average": 0.998002, "min": 0.982172}, "location": {"width": 721, "top": 496, "height": 35, "left": 238}, "words": "生或者在这些患者中更严重的不良事件,以及在该人群中有临床显著性差别的不"}, {"probability": {"variance": 2.1e-05, "average": 0.998041, "min": 0.977335}, "location": {"width": 721, "top": 538, "height": 33, "left": 238}, "words": "良事件,以下均进行了描述。与有实体瘤的患者相比,卡波氏肉瘤的患者中,肝"}, {"probability": {"variance": 1e-06, "average": 0.999122, "min": 0.996131}, "location": {"width": 441, "top": 580, "height": 28, "left": 236}, "words": "功能试验指标升高和肾毒性的发生率有升高趋势"}, {"probability": {"variance": 2e-06, "average": 0.998491, "min": 0.996072}, "location": {"width": 87, "top": 620, "height": 25, "left": 277}, "words": "造血系统"}, {"probability": {"variance": 0.005889, "average": 0.98001, "min": 0.593023}, "location": {"width": 679, "top": 659, "height": 34, "left": 277}, "words": "骨髓抑制是紫杉醇主要的剂量限制性毒性。中性粒细胞减少是最重要的造血"}, {"probability": {"variance": 0.012553, "average": 0.693269, "min": 0.581229}, "location": {"width": 108, "top": 679, "height": 45, "left": 904}, "words": " INGDONG PR"}, {"probability": {"variance": 0.000439, "average": 0.991017, "min": 0.899158}, "location": {"width": 722, "top": 702, "height": 32, "left": 234}, "words": "系统毒性,具有剂量和时间依赖性,通常也可快速恢复。在卵巢癌I线临床"}, {"probability": {"variance": 1e-06, "average": 0.998838, "min": 0.997959}, "location": {"width": 105, "top": 721, "height": 33, "left": 918}, "words": "广东"}, {"probability": {"variance": 0.004374, "average": 0.982526, "min": 0.585748}, "location": {"width": 724, "top": 741, "height": 36, "left": 233}, "words": "研究中,患者接受紫杉醇3小时输注,135mg/m2剂量组中,14%的患者中性粒细"}, {"probability": {"variance": 0.001469, "average": 0.976822, "min": 0.910465}, "location": {"width": 120, "top": 757, "height": 36, "left": 922}, "words": "有限公司"}, {"probability": {"variance": 0.002725, "average": 0.979118, "min": 0.709859}, "location": {"width": 684, "top": 783, "height": 33, "left": 232}, "words": "胞计数低于500/mm3,而175mg/m2组发生率为27%(P=0.05)。同样在本研究"}, {"probability": {"variance": 0.000381, "average": 0.99178, "min": 0.900113}, "location": {"width": 670, "top": 823, "height": 35, "left": 233}, "words": "持续24小时输注发生严重的中性粒细胞减少(<500细胞/m3)的频率高于"}, {"probability": {"variance": 0.000633, "average": 0.993204, "min": 0.849757}, "location": {"width": 726, "top": 863, "height": 37, "left": 232}, "words": "输注组;输注时间对骨髓抑制的影响大于剂量。重复使用并不增加中性粒细胞减"}, {"probability": {"variance": 0.005677, "average": 0.976894, "min": 0.591811}, "location": {"width": 726, "top": 904, "height": 36, "left": 232}, "words": "少的发生,先前接受过放射治疗的患者发生中性粒细胞减少的频率和严重程度也"}, {"probability": {"variance": 5e-06, "average": 0.998049, "min": 0.99408}, "location": {"width": 88, "top": 947, "height": 26, "left": 232}, "words": "没有增加"}, {"probability": {"variance": 0.084436, "average": 0.766152, "min": 0.3565}, "location": {"width": 201, "top": 938, "height": 52, "left": 794}, "words": "上海"}, {"probability": {"variance": 0.001853, "average": 0.981973, "min": 0.764936}, "location": {"width": 679, "top": 988, "height": 33, "left": 276}, "words": "在紫杉醇135mg/m24小时联合顺铂治疗卵巢癌的研究中以环磷酰胺联合"}, {"probability": {"variance": 4.2e-05, "average": 0.997711, "min": 0.961103}, "location": {"width": 766, "top": 1028, "height": 42, "left": 231}, "words": "顺铂为对照组,紫杉醇联合顺铂组Ⅳ级中性粒细胞减少和中性粒细胞减少性发热"}, {"probability": {"variance": 0.008407, "average": 0.978015, "min": 0.470541}, "location": {"width": 754, "top": 1063, "height": 40, "left": 230}, "words": "的发生率高于对照组。紫杉醇联合顺铂组Ⅳ级中性粒细胞减少的发生率为81%3"}, {"probability": {"variance": 8.4e-05, "average": 0.994551, "min": 0.964604}, "location": {"width": 721, "top": 1110, "height": 33, "left": 232}, "words": "而环磷酰胺联合顺铂组的发生率为58%,而两组中性粒细胞减少性发热的发生率"}, {"probability": {"variance": 0.006414, "average": 0.979699, "min": 0.498703}, "location": {"width": 726, "top": 1150, "height": 35, "left": 228}, "words": "分别为15%与4%。在紫杉醇/顺铂组,1074个疗程中的35个(3%)发生发热,同"}, {"probability": {"variance": 0.000406, "average": 0.993484, "min": 0.879389}, "location": {"width": 722, "top": 1190, "height": 36, "left": 228}, "words": "时均伴有Ⅳ级中性粒细胞减少的报道。在针对进展期非小细胞肺癌患者的ECOG"}, {"probability": {"variance": 3.1e-05, "average": 0.997468, "min": 0.971395}, "location": {"width": 723, "top": 1232, "height": 34, "left": 229}, "words": "研究中,紫杉醇继以顺铂治疗时Ⅳ级中性粒细胞减少的发生率为74%(紫杉醇"}, {"probability": {"variance": 0.005114, "average": 0.977415, "min": 0.557209}, "location": {"width": 725, "top": 1275, "height": 34, "left": 230}, "words": "135mg/m224小时后继以顺铂治疗)和65%(紫杉醇250mg/m2124小时后继以顺铂"}, {"probability": {"variance": 0.016994, "average": 0.951303, "min": 0.359404}, "location": {"width": 543, "top": 1317, "height": 28, "left": 230}, "words": "和GCSF治疗),作为对照的顺铂足叶乙组发生率为55%"}, {"probability": {"variance": 5.6e-05, "average": 0.997099, "min": 0.965163}, "location": {"width": 680, "top": 1357, "height": 34, "left": 271}, "words": "发热是很常见的(占所有治疗疗程中的12%)。30%的患者以及9%的疗程中"}, {"probability": {"variance": 5.7e-05, "average": 0.998046, "min": 0.953853}, "location": {"width": 724, "top": 1397, "height": 35, "left": 227}, "words": "均可发生感染,1%患者的感染是致命的,包括脓毒症、肺炎、腹膜炎。在卵巢癌"}, {"probability": {"variance": 0.00601, "average": 0.971165, "min": 0.64272}, "location": {"width": 725, "top": 1438, "height": 36, "left": 226}, "words": "Ⅲ1期二线临床研究中,紫杉醇剂量135mg/m2和175mg/m2持续3小时输注的患者感"}], "language": 3}